Clinical Trial Update: Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nab-paclitaxel in desmoid tumors, desmoplastic small round cell tumors, and Ewing sarcoma; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid Tumor
• Desmoplastic Small Round Cell Tumor
• Ewing Sarcoma

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Grupo Espanol de Investigacion en Sarcomas | Conditions: Tumor, Desmoplastic Small Round Cell, Adult, Tumor, Desmoplastic Small Round Cell, Childhood | Phase 2 | Status: COMPLETED